Business Information
The group's principal activity is to develop and manufacture cardiovascular and vascular medical devices. The main product of the group is angiojet rheolytic thrombectomy system. The angiojet system is a non-surgical, minimally invasive catheter system designed to rapidly remove blood clots with minimal vascular trauma. The group markets its product to interventional cardiologists, interventional radiologists, vascular surgeons and physician specialty groups, such as nephrologists and osteopaths. The group has operations in the United States and the Netherlands.
|
|
Name |
Title
|
Email
|
| Robert Dutcher | Chmn., CEO, Pres. | N/A | | Jules Fisher | CFO, VP - Finance | N/A | | Robert Scott | VP - Manufacturing Operations, Information Technology, Chief Security Officer | N/A | | James Gustafson | Sr. VP - Research, Development, Engineering, Clinical Evaluation, Chief Quality Officer | N/A | | Shawn McCarrey | Exec. VP - Worldwide Sales, Marketing | N/A |
|
|
Year |
Sales |
Net Income |
| 2006 | 61,879 | 809 | | 2005 | 65,053 | 6,155 | | 2004 | 72,420 | 11,729
|
|
| TO SEE COMPLETE RESULTS SUBSCRIBE NOW |
TO SEE COMPLETE RESULTS SUBSCRIBE NOW |
|
Click for more Executives |
|
|
